AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Iowa

HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

Status

Pending

2026 Session

IntroducedMar 27, 2025 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Ways and Means (Republican)
Type: Therapeutic Access
Substances: Psilocybin

Official text

Summary (from PoliPsy)

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: legis.iowa.gov

Legislative history

May 1, 2026
Amendment S-5248 filed. S.J. 960.
March 23, 2026
Referred
January 14, 2026
Referred
April 22, 2025
Referred
April 21, 2025
Engrossed (Passed One Chamber)
March 27, 2025
Introduced

Loading bill…